The A reagent: The A reagent (Table 1 ) was an unabsorbed, isoimmune antiserum. It was produced in a sheep named A, which received five intrajugular injections, at five-day intervals, of 5 ml of citrated blood from a sheep named B. The antiserum was collected five days after the last injection. Sheep A was of blood-group R in the R 0 system, and a preimmunization sample of her serum contained n...

Background: This study was designed to investigate whether there was an association between ABO blood groups and cardiovascular risk factors in healthy population. Methods: In this cross-sectional study, risk factors screening for cardiovascular disease(CVD) on 5000 healthy persons of Golestan Province, northern Iran, in 2005 was estimated by a questionnaire that included age, sex, physical act...

Blood group antigens of the H, ABO, Lewis, and historical “P” blood groups are defined by small carbohydrate epitopes expressed as posttranslational modifications on glycoproteins, mucins, and glycolipids. Their synthesis is complex and dependent on several distinct glycosyltransferases and interrelated biosynthetic pathways. In many cases, carbohydrate antigens share features of more than one ...

The problem of the relation between blood groups and disease has been the subject of many investigations. An important paper appeared as early as 46 years ago (Buchanan and Higley, 1921). Specific studies about blood groups and leprosy also date back to the twenties (Puente, 1927-28 and others). Since that time the relation between the ABO blood groups and this disease has been tested in differ...

Results: In this study, the following pattern of ABO blood groups was observed in IHD patients : blood group A 251 (27.67%); blood group B 329 (36.27%); blood group O 235 (25.91%); blood group AB 92 (10.14%). We found no relationship of ABO blood groups with age (p-value = 0.234), gender (p-value = 0.093), hypertension (p-value = 0.230), diabetes mellitus (p-value = 0.801), family history of IH...

One of the major challenges in developing programs for kidney transplantation is represented by presence antibodies targeting HLA donor recipients and, particular cases, incompatibility ABO blood groups among and recipient living donors [...]